Researchers create first model for retina receptorsOctober 01, 2008Discovery moves scientists a significant step closer to preventing blindness A team of scientists at the University of Oklahoma Health Sciences Center has created the first genetic research model for a microscopic part of the eye that when missing causes blindness. The research appears in a recent issue of the Journal of Biological Chemistry. The team led by OU scientists at Dean McGee Eye Institute also includes researchers from Harvard Medical School. The group is studying how diabetes and insulin receptors affect the eye, and in many cases cause blindness. In diabetes, the insulin receptors malfunction and scientists have yet to figure out why.
"Our hope is to test drug compounds and therapeutic agents to see if they can prolong the life of the receptor cells and either delay or prevent blindness. Therapies could include a pill or gene therapy to activate the malfunctioning receptor," said Raju Rajala, Ph.D., principal investigator on the project. Rajala said researchers expect to have some form of therapy available within 15 years. They are focusing on an insulin receptor in the eye's rods, which are part of the retina. The rods translate what we see into electric signals to the brain. When the receptors aren't working, blindness occurs. To learn more about how the receptors work and how proteins and insulin play a role in their function, scientists needed a research model to test their ideas. With the new model at OU, scientists hope to find ways to significantly delay blindness or prevent it, especially in patients with diabetic retinopathy. Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in the blood vessels of the retina. In some people with diabetic retinopathy, blood vessels may swell and leak fluid. In other people, abnormal new blood vessels grow on the surface of the retina. A healthy retina is necessary for good vision. "We are looking for clues to understand the progression of diabetic retinopathy so we can eventually stop it," Rajala said. "We still don't understand why the receptors malfunction or what their defense mechanism is. We needed a model to understand this process and now we have one." University of Oklahoma | |||||||||||||||||||||
|
Related Blindness Current Events and Blindness News Articles Researchers engineer pancreatic cell transplants to evade immune response In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients. Study of revlimid and vidaza in higher-risk MDS is well-tolerated and has high activity Celgene International Sarl (NASDAQ: CELG) reported that results of a Phase I study presented today combining REVLIMID and VIDAZA in patients with higher-risk myelodysplastic syndromes (MDS) found that the combination of these two therapies is well tolerated and has high activity. Studies examine quality of care for hospitalized sickle cell disease patients A study assessing the quality of care for patients with sickle cell disease in a variety of hospital settings will be presented at a press conference on Saturday, December 6, at 9:30 a.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA. Progression of retinal disease linked to cell starvation Rods and cones coexist peacefully in healthy retinas. Both types of cells occupy the same layer of tissue and send signals when they detect light, which is the first step in vision. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses. New technique captures high-res images of full retina Researchers used a new imaging technique to take high quality color photographs of the clinical stages of ocular inflammation in mice, and the technology could help in the monitoring and treatment of diseases of the eye that may cause blindness. Drivers make more errors when talking on cell phone than to a passenger Drivers make more mistakes when talking on a cell phone than when talking to passengers, new research shows. Carnegie Mellon scientists offer explanation for 'face blindness' For the first time, scientists have been able to map the disruption in neural circuitry of people suffering from congenital prosopagnosia, sometimes known as face blindness, and have been able to offer a biological explanation for this intriguing disorder. Melatonin may save eyesight in inflammatory disease Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. The related report by Sande et al., "Therapeutic Effect of Melatonin in Experimental Uveitis," appears in the December issue of The American Journal of Pathology. Conference report highlights new research into drug delivery to treat eye disease Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference. More Blindness Current Events and Blindness News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||